Fundraising FoxOrganoid Therapeutics
Irwin, US · Founded 2019 · Delaware corporation
Find your way into Organoid Therapeutics
Sign up to see every warm intro you have to Organoid Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Organoid Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DS
David S SmithNamed on SEC filing
RL
Ricardo LondonoNamed on SEC filing
DF
Denver FaulkNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$445K disclosed across 1 round · 2020
▶$445KraisedMar 2020 · 9 investors · Other Health CareRule 506(b)
▶$445KraisedMar 2020 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David S SmithExecutive Officer
- Ricardo LondonoExecutive Officer, Director
- Denver FaulkExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $445K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Organoid Therapeutics raised?
- Organoid Therapeutics has disclosed $445K raised across 1 round.
- Where is Organoid Therapeutics headquartered?
- Organoid Therapeutics is headquartered in Irwin, US.